Company News

  • Snibe become the 1st in China who received FDA Cleared on CLIA product

    Release Date:2017-10-27

    14th July 2017- Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on MaglumiTM 2000 fully-automatic chemiluminescence immunoassay system. (US FDA 510 (k), K NO. : K162698) .It is the 1st company in China who received FDA cleared on CLIA product.
  • Snibe shines at AACC 2018

    View Count:369

    The 70th AACC Annual Scientific Meeting & Clinical Lab Expo., attracting more than 22,000 visitors and 500 exhibitors to share the most recent technology available in the medical laboratory market, was held at McCormick Place, Chicago, USA from Jul. 29 to Aug. 2.
  • Snibe attends MEDICONEX in Cairo, Egypt

    View Count:633

    The largest healthcare platform across North Africa, MEDICONEX, was held at Egypt International Exhibition Center (EIEC), Cairo, Egypt from Apr. 14th to 16th, 2018.
  • Snibe shines at MEDLAB Asia Pacific 2018 in Singapore

    View Count:643

    SNIBE attended MEDLAB Asia Pacific 2018 in Singapore from 2nd to 4th in April. With a 72sqm well-decorated exhibition stand at Booth No.K10, SNIBE has successfully showcased its excellent MAGLUMI Chemiluminescence Immunoassay (CLIA) system and Integrated System.
  • Snibe attends MEDLAB 2018 in Dubai

    View Count:918

    MEDLAB Middle East, one of the largest laboratory exhibitions, is held in Dubai, United Arab Emirates, from February 5th to 8th, which attracts more than 25,000 attendees from 129 countries across the world.